Wells Fargo’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,231
| Closed | – | – | 7543 |
|
|
2022
Q3 | $0 | Buy |
1,231
+5
| +0.4% | – | ﹤0.01% | 7509 |
|
|
2022
Q2 | $0 | Buy |
1,226
+10
| +0.8% | – | ﹤0.01% | 7574 |
|
|
2022
Q1 | $1K | Buy |
1,216
+3
| +0.2% | +$2 | ﹤0.01% | 6570 |
|
|
2021
Q4 | $3K | Hold |
1,213
| – | – | ﹤0.01% | 6293 |
|
|
2021
Q3 | $6K | Buy |
1,213
+612
| +102% | +$3.03K | ﹤0.01% | 6021 |
|
|
2021
Q2 | $2K | Sell |
601
-100,783
| -99% | -$335K | ﹤0.01% | 6250 |
|
|
2021
Q1 | $739K | Buy |
101,384
+83,300
| +461% | +$607K | ﹤0.01% | 4175 |
|
|
2020
Q4 | $138K | Buy |
18,084
+5,696
| +46% | +$43.5K | ﹤0.01% | 5086 |
|
|
2020
Q3 | $112K | Sell |
12,388
-3,155
| -20% | -$28.5K | ﹤0.01% | 5026 |
|
|
2020
Q2 | $131K | Buy |
15,543
+5,934
| +62% | +$50K | ﹤0.01% | 4904 |
|
|
2020
Q1 | $47K | Sell |
9,609
-374
| -4% | -$1.83K | ﹤0.01% | 5135 |
|
|
2019
Q4 | $72K | Buy |
9,983
+11
| +0.1% | +$79 | ﹤0.01% | 5178 |
|
|
2019
Q3 | $107K | Buy |
9,972
+253
| +3% | +$2.72K | ﹤0.01% | 5063 |
|
|
2019
Q2 | $126K | Buy |
9,719
+230
| +2% | +$2.98K | ﹤0.01% | 4991 |
|
|
2019
Q1 | $94K | Buy |
9,489
+89
| +0.9% | +$882 | ﹤0.01% | 5070 |
|
|
2018
Q4 | $97K | Buy |
+9,400
| New | +$97K | ﹤0.01% | 5057 |
|